Pfizer slumped by 36%, is it a good buy in 2024? by Thea Coates Finance Reporter January 25, 2024 January 25, 2024
UK regulator approves use of Pfizer/BioNTech vaccine in 5 to 11-year olds by LLB Reporter December 23, 2021 December 23, 2021
Three doses of Pfizer vaccine ‘neutralises Omicron,’ but two ‘may not be sufficient to protect against infection’ by LLB staff reporter December 8, 2021 December 8, 2021
Pfizer’s new Covid wonderpill cuts hospitalisations and death by 89% by LLB Reporter November 5, 2021 November 5, 2021
Which UK stocks have done best since Pfizer Monday? by LLB Reporter November 4, 2021 November 4, 2021
Entia raise $12m to launch virtual oncology solution in partnership with Pfizer UK by LLB Finance Reporter October 7, 2021 October 7, 2021
Pfizer booster jab needed against Indian variant as it ‘works less well’ by LLB Reporter June 4, 2021 June 4, 2021
Vaccinating children could cause a spike in parent disputes by LLB Reporter June 4, 2021 June 4, 2021
Pfizer vaccine approved for 12 to 15-year-olds in the UK by LLB staff reporter June 4, 2021 June 4, 2021
